Co-infección de la Hepatitis B o C en población VIH positiva del Callao - Perú. 2016.
Descripción del Articulo
Objective: To determine the frequency and factors associated with Hepatitis B or C coinfection in HIV-infected population, in Callao Region, 2016. Methodology: Descriptive, cross-sectional, retrospective study that included samples of HIV infected persons previously confirmed by the HIV LRN, these s...
Autores: | , |
---|---|
Formato: | otro |
Fecha de Publicación: | 2019 |
Institución: | Universidad Nacional de Trujillo |
Repositorio: | UNITRU-Tesis |
Lenguaje: | español |
OAI Identifier: | oai:dspace.unitru.edu.pe:20.500.14414/15035 |
Enlace del recurso: | https://hdl.handle.net/20.500.14414/15035 |
Nivel de acceso: | acceso abierto |
Materia: | Virus de Iinmudeficiencia Humana Hepatitis B Hepatitis C |
Sumario: | Objective: To determine the frequency and factors associated with Hepatitis B or C coinfection in HIV-infected population, in Callao Region, 2016. Methodology: Descriptive, cross-sectional, retrospective study that included samples of HIV infected persons previously confirmed by the HIV LRN, these samples came from the Callao Region, in 2016. A base was prepared and 87 samples were selected that met the inclusion criteria. These samples were performed with the ELISA test to determine the presence of the markers for HBsAg HBV and anti HCV-core HCV. For the data analysis, the statistical package SPSS version 23 was used. Since it is a descriptive prevalence study, inference or statistical estimation of the prevalence was applied. Descriptive statistics were performed; to establish frequencies and percentages, to correlate dependent and independent variables and correlation of variables through the Chi-square statistic. Results: Of the group of samples studied, 23% are women, 51.7% come from the district of Callao, the most affected age group was 25 to 34 years (35.63%), followed by from 16 to 20 years (20.69%), 2% are under 15 years old, 18.9% of the participants are in the AIDS phase. As for the risk group, 78% correspond to the general population. The prevalence of HIV-HCV coinfection was 1.11%. No positive results were found for the HBsAg marker, so HIV-HBV coinfection was not evident. Conclusions: The determination of HIV-HCV coinfection is very important because it allows the patient to access an appropriate treatment to give a better quality of life. |
---|
Nota importante:
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).